Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 25
Submit an article Journal homepage
134
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Upregulated HMGB1 levels in maternal–fetal interface of patients with unexplained recurrent spontaneous abortion from different sources

Jing Wanga Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;b NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), Hefei, China;c Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, Hefei, ChinaView further author information
,
Damin Zhub NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), Hefei, China;c Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, Hefei, China;d Department of Obstetrics and Gynecology, Chaohu Hospital of Anhui Medical University, Chaohu, ChinaView further author information
,
Jiaqian Yina Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;e Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, China;f Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, ChinaView further author information
,
Cong Maa Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;e Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, China;f Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, ChinaView further author information
,
Xiaoqing Penga Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;e Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, China;f Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, ChinaView further author information
,
Huijuan Zoua Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;e Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, China;f Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, ChinaView further author information
,
Yunxia Caoa Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;e Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, China;f Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, ChinaView further author information
&
Xiaofeng Xua Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China;b NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), Hefei, China;c Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, Hefei, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 6542-6549 | Received 09 Sep 2020, Accepted 13 Apr 2021, Published online: 04 May 2021

References

  • Youssef A, Vermeulen N, Lashley E, et al. Comparison and appraisal of (inter) national recurrent pregnancy loss guidelines. Reprod Biomed Online. 2019;39(3):497–503.
  • Szekeres-Bartho J, Balasch J. Progestagen therapy for recurrent miscarriage. Hum Reprod Update. 2008;14(1):27–35.
  • Yang F, Zheng Q, Jin L. Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface. Front Immunol. 2019;10:2317.
  • Bulla R, Bossi F, Tedesco F. The complement system at the embryo implantation site: friend or foe? Front Immunol. 2012;3:55.
  • Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol. 2007;29(2):95–113.
  • Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 2018;22(3):263–277.
  • Bianchi ME, Beltrame M, Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science. 1989;243(4894 Pt 1):1056–1059.
  • Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191–195.
  • Venereau E, Schiraldi M, Uguccioni M, et al. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol. 2013;55(1):76–82.
  • Saito Reis CA, Padron JG, Norman Ing ND, et al. High-mobility group box 1 is a driver of inflammation throughout pregnancy. Am J Reprod Immunol. 2021;85(1):e13328.
  • Li JH, Zhao B, Zhu XH, et al. Blockade of extracellular HMGB1 suppresses xenoreactive B cell responses and delays acute vascular xenogeneic rejection. Am J Transplant. 2015;15(8):2062–2074.
  • Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1. J Leukoc Biol. 2005;78(1):1–8.
  • Nadeau-Vallee M, Obari D, Palacios J, et al. Sterile inflammation and pregnancy complications: a review. Reproduction. 2016;152(6):R277–R292.
  • Zou HJ, Yin JQ, Zhang ZG, et al. Destruction in maternal-fetal interface of URSA patients via the increase of the HMGB1-RAGE/TLR2/TLR4-NF-κB signaling pathway. Life Sci. 2020;250:117543.
  • Heikkinen J, Möttönen M, Komi J, et al. Phenotypic characterization of human decidual macrophages. Clin Exp Immunol. 2003;131(3):498–505.
  • Naruse K, Sado T, Noguchi T, et al. Peripheral RAGE (Receptor for Advanced Glycation Endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response. J Reprod Immunol. 2012;93(2):69–74.
  • Cupurdija K, Azzola D, Hainz U, et al. Macrophages of human first trimester decidua express markers associated to alternative activation. Am J Reprod Immunol. 2004;51(2):117–122.
  • Bhutada S, Basak T, Savardekar L, et al. High mobility group box 1 (HMGB1) protein in human uterine fluid and its relevance in implantation. Hum Reprod. 2014;29(4):763–780.
  • Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol. 2004;34(6):1503–1512.
  • Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40–48.
  • Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal–maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014;5:125.
  • Widdows K, Kingdom JC, Ansari T. Double immuno-labelling of proliferating villous cytotrophoblasts in thick paraffin sections: integrating immuno-histochemistry and stereology in the human placenta. Placenta. 2009;30(8):735–738.
  • Dhaenens L, Lierman S, De Clerck L, et al. Endometrial stromal cell proteome mapping in repeated implantation failure and recurrent pregnancy loss cases and fertile women. Reprod Biomed Online. 2019;38(3):442–454.
  • Stephen GL, Lui S, Hamilton SA, et al. Transcriptomic profiling of human choriodecidua during term labor: inflammation as a key driver of labor. Am J Reprod Immunol. 2015;73(1):36–55.
  • Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141(3):347–357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.